west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "可切除性" 5 results
  • Assessment of Laparoscopic Resectablity of Carcinoma of Gallbladder

    Release date:2016-09-08 10:37 Export PDF Favorites Scan
  • Pancreatic Carcinoma: Diagnosis and Preoperative Resectability Assessment by Using Gd-DTPA 3D FSPGR Dynamic MR Imaging

    ObjectiveTo study the value of Gd-DTPA three dimension fast spoiled gradientecho (3D FSPGR) dynamic MRI in the diagnosis and preoperative respectability assessment of pancreatic carcinoma.MethodsThirty-two cases of pancreatic carcinoma verified by surgery and pathology were included in this study. All of the cases had MRI examinations two weeks before surgery. MRI protocols involved gradient echo T1 weighted(GRE T1W) with fat suppression, fast spin echo respiratory gating T2 weighted (FSE RG T2W) with fat suppression, MR cholangiopancreatography (MRCP) and gadolinium chelate 3D FSPGR T1W dynamic enhancement. Two radiologists reviewed MRI of the 32 cases retrospectively. Preoperative resectability of pancreatic carcinoma was assessed according to the characteristics of tumor lesions, peripancreatic invasion, vascular invasion, lymph node metastases, and liver metastases. The diagnosis and preoperative resectability assessment of pancreatic carcinoma by MRI was compared with surgical findings. ResultsOf 32 cases, 29 cases diagnosed by MRI were confirmed by surgery and pathology (accuracy of MRI, 90.6%). The sensitivity was 84.4%(27/32) and 93.8%(30/32) respectively for GRE T1W with fat-suppression combining FSE RG T2W and for Gd-DTPA 3D FSPGR dynamic MRI in the detection of pancreatic tumors. The accuracy was 87.5%(21/24), 87.0%(20/23), 80.0%(12/15), 88.9%(8/9) and 83.3%(5/6) respectively for Gd-DTPA 3D FSPGR dynamic MRI in assessing local extension, vascular invasion, lymph node metastases, liver metastases and peritoneal carcinomatosis of pancreatic carcinoma. Eight cases of pancreatic carcinoma were considered to be resectable by enhanced MRI, while the tumors in 7 cases of the 8 cases were resected by surgery. Twentythree cases were confirmed nonresectable by surgery in the 24 cases of pancreatic carcinoma considered to be non-resectable by enhanced MRI. The sensitivity, specificity and accuracy were 87.5%,95.8% and 93.8% resectability for the assessment of respectability of pancreatic carcinoma by using Gd-DTPA 3D FSPGR dynamic MRI. There was no significant difference in the assessment of the resectability of pancreatic carcinoma between enhanced MRI and surgery or pathology (κ=0.83).ConclusionUsing of Gd-DTPA 3D FSPGR dynamic enhanced MRI improves the detections of pancreatic carcinoma and metastasis. It is also accurate in the assessment of the resectability of pancreatic carcinoma.

    Release date:2016-09-08 11:54 Export PDF Favorites Scan
  • EVALUATION OF RESECTABILITY FOR PANCREATIC HEAD CARCINOMA WITH DUAL-PHASE THINSLICE SPIRAL CT

    目的 探讨螺旋CT双期薄层增强扫描对胰头癌可切除性的评估价值。方法 回顾性分析24例经螺旋CT双期薄层增强扫描胰头癌的CT表现,观察肿块对邻近器官或组织侵犯情况,以及有无远处器官和淋巴结转移,据此判断肿块能否切除,并将其结果与手术病理结果相对照。结果 螺旋CT判断胰头癌可切除的敏感性为90.9%,特异性为84.6%,阳性预测值为83.3%,阴性预测值为91.7%,准确性为87.5%。结论 螺旋CT双期薄层增强扫描判断胰头癌可切除性的价值较高,对外科医生选择最佳治疗方案有较大的帮助。

    Release date:2016-09-08 02:01 Export PDF Favorites Scan
  • The Preoperative Resectability Assessment of Hilar Cholangiocarcinoma

    Release date: Export PDF Favorites Scan
  • 临界可切除胰腺癌的肿瘤标志物检测

    目的研究临界可切除胰腺癌的肿瘤标志物的临床特点。 方法回顾性分析我院2012年1月至2015年12月期间收治的52例胰腺癌患者中的20例临界可切除胰腺癌患者术前CA19-9、CA125及CEA水平,并与不可切除胰腺癌(23例)、可切除胰腺癌(9例)患者术前的肿瘤标志物水平进行比较。 结果临界可切除胰腺癌患者血清中的CA19-9(U/mL)、CA125(U/mL)及CEA(μg/L)水平均明显低于不可切除胰腺癌患者(278.5±23.9比546.2±34.8,P<0.05;125.3±19.6比217.8±24.9,P<0.05;11.6±2.5比19.4±3.9,P<0.05),但明显高于可切除胰腺癌患者(278.5±23.9比131.4±25.6,P<0.05;125.3±19.6比97.8±19.9,P<0.05;11.6±2.5比7.1±3.0,P<0.05)。临界可切除胰腺癌患者的术后生存时间(月)明显长于不可切除胰腺癌患者(26.9±4.8比11.5±7.2,P<0.05),与可切除胰腺癌患者比较差异无统计学意义(26.9±4.8比28.5±3.2,P>0.05)。临界可切除胰腺癌患者术后发生并发症5例,其中轻、重度胰漏4例,消化道大出血1例,所有并发症通过引流、抑制胰酶分泌、输血、营养支持等保守治疗治愈,无手术导致的死亡。可切除胰腺癌患者术后发生并发症3例,其中胆汁漏1例,胰漏1例,肠梗阻1例,均保守治疗治愈。 结论临界可切除胰腺癌患者术前血清CA19-9、CA125及CEA水平与不可切除胰腺癌患者和可切除胰腺癌患者有一定的差异,具有与影像学特点相对应的临床特点,结合术前MDCT结果可辅助判别胰腺肿瘤手术切除可能,减少不必要的剖腹探查。

    Release date:2016-10-02 04:54 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content